questionText: To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with pharmaceutical companies on ensuring adequate supplies of (a) enzyme replacement therapy and (b) other related medications.
answerText: We are aware of the supply issues with the three enzyme replacement therapies, Creon 10,000 gastro-resistant capsules, Creon 25,000 gastro-resistant capsules, and Nutrizym 22 capsules. These are due to manufacturing and active pharmaceutical ingredient co...
heading: Enzyme Replacement Therapy